These changes were associated with higher circulating TNF-α (consistent with low-grade inflammation), decreased myocardial AMP-Activated Protein Kinase (AMPK) activation, and increased myocardial fibrosis. The gene discussed is PRKAA1; the disease is Myocardial fibrosis.